Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company engaged in developing, manufacturing, and distributing a diverse portfolio of healthcare products. The company’s operations span both domestic and international markets, focusing on the production of general pharmaceutical tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Curis Lifesciences caters to a wide client base, serving over 100 corporate customers through loan licence and contract manufacturing arrangements, while also promoting its own brands in markets such as Yemen and Kenya. Its modern manufacturing facility in Sanand, Gujarat, is equipped with advanced technology and follows strict quality control standards to maintain consistency and safety across all products.
The company’s business model is divided into three main categories — loan licence manufacturing, contract manufacturing, and direct export or own brand marketing. Under the loan licence vertical, clients provide raw materials, excipients, and necessary documentation, while Curis Lifesciences undertakes the production process under the supervision of a customer-appointed chemist. This model ensures flexibility and compliance with client requirements. The company employs 95 permanent staff as of July 31, 2025, and continues to strengthen its position in the pharmaceutical industry by combining manufacturing expertise with adherence to regulatory standards and customer-oriented practices.